US 11752214
Protein-antiviral compound conjugates
granted A61KA61K31/506A61K31/5383
Quick answer
US patent 11752214 (Protein-antiviral compound conjugates) held by REGENERON PHARMACEUTICALS, INC. expires Mon Sep 07 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Sep 12 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 07 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61K, A61K31/506, A61K31/5383, A61K47/6801, A61K47/6803